Zipp F - Search Results

1

Correlation of self-assessed fatigue and alertness in multiple sclerosis.

Weinges-Evers N, Brandt AU, Bock M, Pfueller CF, Dörr J, Bellmann-Strobl J, Scherer P, Urbanek C, Boers C, Ohlraun S, Zipp F, Paul F. Weinges-Evers N, et al. Among authors: zipp f. Mult Scler. 2010 Sep;16(9):1134-40. doi: 10.1177/1352458510374202. Epub 2010 Jul 7. Mult Scler. 2010. PMID: 20610494

2

Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.

Wendling U, Walczak H, Dörr J, Jaboci C, Weller M, Krammer PH, Zipp F. Wendling U, et al. Among authors: zipp f. Cell Death Differ. 2000 Jul;7(7):637-44. doi: 10.1038/sj.cdd.4400692. Cell Death Differ. 2000. PMID: 10889508

3

Induction of TRAIL-mediated glioma cell death by human T cells.

Dörr J, Waiczies S, Wendling U, Seeger B, Zipp F. Dörr J, et al. Among authors: zipp f. J Neuroimmunol. 2002 Jan;122(1-2):117-24. doi: 10.1016/s0165-5728(01)00450-7. J Neuroimmunol. 2002. PMID: 11777550

4

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain.

Dörr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH, Nitsch R, Zipp F. Dörr J, et al. Among authors: zipp f. J Neurosci. 2002 Feb 15;22(4):RC209. doi: 10.1523/JNEUROSCI.22-04-j0001.2002. J Neurosci. 2002. PMID: 11844843 Free PMC article.

5

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.

Aktas O, Waiczies S, Smorodchenko A, Dorr J, Seeger B, Prozorovski T, Sallach S, Endres M, Brocke S, Nitsch R, Zipp F. Aktas O, et al. Among authors: zipp f. J Exp Med. 2003 Mar 17;197(6):725-33. doi: 10.1084/jem.20021425. Epub 2003 Mar 10. J Exp Med. 2003. PMID: 12629065 Free PMC article.

6

Systemic IFN-beta treatment induces apoptosis of peripheral immune cells in MS patients.

Gniadek P, Aktas O, Wandinger KP, Bellmann-Strobl J, Wengert O, Weber A, von Wussow P, Obert HJ, Zipp F. Gniadek P, et al. Among authors: zipp f. J Neuroimmunol. 2003 Apr;137(1-2):187-96. doi: 10.1016/s0165-5728(03)00074-2. J Neuroimmunol. 2003. PMID: 12667663 Clinical Trial.

7

Wandinger KP, Lünemann JD, Wengert O, Bellmann-Strobl J, Aktas O, Weber A, Grundström E, Ehrlich S, Wernecke KD, Volk HD, Zipp F. Wandinger KP, et al. Among authors: zipp f. Lancet. 2003 Jun 14;361(9374):2036-43. doi: 10.1016/S0140-6736(03)13641-0. Lancet. 2003. PMID: 12814715

8

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study.

Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A, Zipp F. Wuerfel J, et al. Among authors: zipp f. Brain. 2004 Jan;127(Pt 1):111-9. doi: 10.1093/brain/awh007. Epub 2003 Oct 21. Brain. 2004. PMID: 14570816

9

A genome-wide German screen for linkage disequilibrium in multiple sclerosis.

Weber A, Infante-Duarte C, Sawcer S, Setakis E, Bellmann-Strobl J, Hensiek A, Rueckert S, Schoenemann C, Benediktsson K, Compston A, Zipp F. Weber A, et al. Among authors: zipp f. J Neuroimmunol. 2003 Oct;143(1-2):79-83. doi: 10.1016/j.jneuroim.2003.08.016. J Neuroimmunol. 2003. PMID: 14575919

10

Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study.

Schmierer K, Altmann DR, Kassim N, Kitzler H, Kerskens CM, Doege CA, Aktas O, Lünemann JD, Miller DH, Zipp F, Villringer A. Schmierer K, et al. Among authors: zipp f. Mult Scler. 2004 Apr;10(2):182-7. doi: 10.1191/1352458504ms996oa. Mult Scler. 2004. PMID: 15124765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters